Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

NCT04362553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2022-09-28

No results posted yet for this study

Summary

Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

wearable vital signs sensor

vital signs monitoring during standard of care procedures; TTE, swan-ganz catheterization

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-11-23
Completion
2022-09-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04362553 on ClinicalTrials.gov